Canada markets closed

Orchestra BioMed Holdings, Inc. (OBIO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.7100-0.2400 (-4.85%)
At close: 04:00PM EDT
4.7100 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 168.55M
Enterprise Value 82.65M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)56.70
Price/Book (mrq)2.48
Enterprise Value/Revenue 2.73k
Enterprise Value/EBITDA -15.53

Trading Information

Stock Price History

Beta (5Y Monthly) 0.22
52-Week Change 3-72.98%
S&P500 52-Week Change 326.27%
52 Week High 320.1900
52 Week Low 34.2200
50-Day Moving Average 35.1814
200-Day Moving Average 36.4535

Share Statistics

Avg Vol (3 month) 342.65k
Avg Vol (10 day) 339.74k
Shares Outstanding 535.79M
Implied Shares Outstanding 635.79M
Float 819.46M
% Held by Insiders 132.16%
% Held by Institutions 142.01%
Shares Short (Apr 30, 2024) 4856.26k
Short Ratio (Apr 30, 2024) 424
Short % of Float (Apr 30, 2024) 44.47%
Short % of Shares Outstanding (Apr 30, 2024) 42.39%
Shares Short (prior month Mar 28, 2024) 4858.02k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,763.74%

Management Effectiveness

Return on Assets (ttm)-33.75%
Return on Equity (ttm)-81.47%

Income Statement

Revenue (ttm)2.76M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)-76.20%
Gross Profit (ttm)N/A
EBITDA -51.22M
Net Income Avi to Common (ttm)-49.12M
Diluted EPS (ttm)-1.4800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)87.59M
Total Cash Per Share (mrq)2.45
Total Debt (mrq)1.69M
Total Debt/Equity (mrq)2.48%
Current Ratio (mrq)7.95
Book Value Per Share (mrq)1.90

Cash Flow Statement

Operating Cash Flow (ttm)-46.13M
Levered Free Cash Flow (ttm)-32.17M